Sandoz US News

sandoz_us_news.jpg

Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines

Princeton, New Jersey, November 22, 2016. Sandoz today announced a collaboration to increase access to medicines by donating up to USD 10 million of stock annually to Americares, a health-focused relief and development organization that responds to people affected by poverty or disaster with life-changing health programs, medicine and medical supplies.

Sandoz launches authorized generic version of Beyaz®

Sandoz today announced the U.S. market introduction of the authorized generic version of Beyaz® (drospirenone/ethinyl estradiol/ levomefolate calcium tablets and levomefolate calcium tablets) mg/0.02 mg/0.451 mg and 0.451 mg, by Bayer

FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases

Erelzi is the first biosimilar etanercept approved by the FDA, offering expanded access to this important medicine. Erelzi is approved for all indications included in the reference product’s label. Erelzi is the second biosimilar from Sandoz to receive FDA approval in the US, building upon established global leadership in biosimilars

Sandoz Careers

sandoz_careers.jpg

Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

 Learn more about a career with Sandoz in the US

 

Vets Hiring 300

Transitioning to civilian service soon? Consider a career with Sandoz, a Novartis company. Learn about our mission, and why you should explore being a part of our team.

  •  

     

     

Slideshow Background Images